Mizuho lowered the firm’s price target on Dentsply Sirona (XRAY) to $16 from $18 and keeps a Neutral rating on the shares. The firm believes many companies in the dental sector “may post less-than-stellar growth” in Q1. The recent American Dental Association Q1 survey results further reinforce a cautious view, so Mizuho trimmed Q1 estimates for broad dental manufacturers, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona downgraded to Equal Weight at Morgan Stanley
- Dentsply Sirona downgraded to Equal Weight from Overweight at Morgan Stanley
- Dentsply Sirona price target lowered to $16 from $19 at BofA
- Dentsply Sirona files automatic mixed securities shelf
- Dentsply Sirona appoints David Ferguson as SVP, global business unit leader